NCT00134966 A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa Status COMPLETED Phase PHASE3
NCT00134251 Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease Status COMPLETED Phase PHASE3
NCT00132626 Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome Status COMPLETED Phase PHASE2
NCT00125138 Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT00122174 Stress-Busting Program for Caregivers of Patients With Neruological Diseases Status COMPLETED Phase NA
NCT00117195 A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease Status COMPLETED Phase N/A
NCT00111982 Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin Status COMPLETED Phase PHASE1/PHASE2
NCT00105521 Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Status COMPLETED Phase PHASE3
NCT00105508 Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Status COMPLETED Phase PHASE3
NCT00104585 Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) Status COMPLETED Phase N/A
NCT00103597 Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy Status COMPLETED Phase PHASE1
NCT00099268 Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy Status COMPLETED Phase PHASE3
NCT00095810 Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease Status COMPLETED Phase PHASE4
NCT00087542 Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug Status COMPLETED Phase PHASE2
NCT00070941 SAM-e for the Treatment of Depression in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00070928 Valerian to Improve Sleep in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT00063193 National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial Status COMPLETED Phase PHASE2